LPL Financial LLC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
LPL Financial LLC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$135,956
-19.6%
105,392
+7.3%
0.00%
Q2 2023$169,016
+90.5%
98,265
+67.2%
0.00%
Q1 2023$88,735
-5.6%
58,7650.0%0.00%
Q4 2022$94,024
+16.1%
58,765
+5.4%
0.00%
Q3 2022$81,000
+26.6%
55,765
+60.5%
0.00%
Q2 2022$64,000
-34.0%
34,740
+82.1%
0.00%
Q3 2021$97,000
-47.8%
19,075
-35.1%
0.00%
Q2 2021$186,000
+5.1%
29,400
+28.4%
0.00%
Q1 2021$177,00022,9000.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BVF INC/IL 5,576,471$36,526,0001.44%
Altium Capital Management LP 273,703$1,793,0000.67%
Jackson Creek Investment Advisors LLC 80,367$526,0000.21%
HARBOURVEST PARTNERS LLC 79,193$519,0000.20%
XTX MARKETS LLC 14,169$93,0000.19%
Perceptive Advisors 2,577,043$16,880,0000.18%
RTW INVESTMENTS, LP 1,527,352$10,004,0000.17%
Exane Asset Management 30,568$200,220,0000.14%
Virtus ETF Advisers LLC 37,343$245,0000.10%
Congress Park Capital LLC 25,807$169,0000.10%
View complete list of CYTOMX THERAPEUTICS INC shareholders